ClinicalTrials.gg
CompletedNCT06628960SujokUpdated Nov 3, 2026

Effect of Su Jok Therapy on Breastfeeding

An interventional study of Su Jok Therapy in Breastfeeding, sponsored by Aysegul Kilicli. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 19 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Aysegul Kilicli · Not applicable, Interventional, and Other

How we know

Updated Nov 3, 2026Now CompletedFirst site in Turkey (Türkiye)+7 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
19 Years to 35 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 274 studies in Breast Feeding with a site in Turkey — 68 open to participants now, 77 under way, none of them phase 3. Breast Feeding · Turkey.

Enrollment
199th of 252
60 · median 80
Started
2024
with 51 others
No phase
251 of 274
65 open now
Registered
150th of 274
by date

Among the 274 studies in Breast Feeding with a site in Turkey, this one is the 199th largest by enrollment of the 252 interventional ones that give a count, is one of 52 that started in 2024, is one of 251 with no phase, and was the 150th registered.

Breast Feeding

1,083 studies on the registry are indexed under Breast Feeding; 216 are open to participants now.

Browse Breast Feeding studies →

Open to participants now

68 of the 274 studies in Breast Feeding with a site in Turkey are open now. Recruiting first, the newest first:

63 more — sign in →

All 68 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 125 Breast Feeding studies recruiting now, 65 (52%) set no upper age limit and 58 (46%) stop at 75 or younger; 52 take children under 18; 75 take healthy volunteers.

This study: 19 Years to 35 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 274 studies in Breast Feeding with a site in Turkey, or all of them as a file.
02

Study summary

There are many alternative methods to increase breast milk. In the literature, studies on Su Jok therapy applications are limited and no studies on increasing breast milk have been found. In Korean language, 'Su' means hand and 'Jok' means foot. Su Jok therapy is defined as a modern acupressure/acupuncture interpretation that utilises the body's independent communication systems on the hands and feet by applying various techniques such as massage, moxa (heating), needles, magnets and seeds to the reflection points on the hands and feet. Su Jok is an integrated therapy that incorporates many tried and trusted methods of oriental medicine

Read the detailed description

There are many alternative methods to increase breast milk. In the literature, studies on Su Jok therapy applications are limited and no studies on increasing breast milk have been found. In Korean language, 'Su' means hand and 'Jok' means foot. Su Jok therapy is defined as a modern acupressure/acupuncture interpretation that utilises the body's independent communication systems on the hands and feet by applying various techniques such as massage, moxa (heating), needles, magnets and seeds to the reflection points on the hands and feet. Su Jok is an integrated therapy that incorporates many tried and trusted methods of oriental medicine.

03

Conditions studied

  • Breastfeeding

Browse trials for

Keywords

  • Su Jok therapy
  • cesarean section
  • breastfeeding
04

Who can participate

Ages eligible
19 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • primiparous women giving birth by caesarean section,
  • women aged 19-35,
  • breastfeeding women

Exclusion criteria

Exclusion Criteria:

  • those who refused to participate in the research
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    su jok therapy;

    su jok therapy; application of seeds placed at certain points on the palm of the hand every day for the first ten days after birth, every day to be kept in the hand for 4 hours.

    Behavioral: Su Jok Therapy

  • No intervention
    control group

    control group, Su Jok will not be applied

Interventions

  • BehavioralSu Jok Therapy

    Su Jok Therapy

06

What researchers measure

Primary outcomes

  1. Breastfeeding Self-Efficacy Scale

    It was developed by Dennis (2003). Its Turkish validity and reliability was conducted by Aluş Tokat et al. (2010). The scale consists of 14 items and is in five-point Likert type. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy.

    Time frame: Pre-test; before the first Su Jok intervention

  2. Breastfeeding Self-Efficacy Scale

    It was developed by Dennis (2003). Its Turkish validity and reliability was conducted by Aluş Tokat et al. (2010). The scale consists of 14 items and is in five-point Likert type. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy.

    Time frame: On the 3rd day after cesarean section (72 hours postpartum), before the 3rd Su Jok intervention.

  3. Breastfeeding Self-Efficacy Scale

    It was developed by Dennis (2003). Its Turkish validity and reliability was conducted by Aluş Tokat et al. (2010). The scale consists of 14 items and is in five-point Likert type. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy.

    Time frame: On the 10th day after cesarean section; after the last (10th) Su Jok intervention.

  4. Breastfeeding Charting System: LATCH

    It was developed by Jensen et al. (1994). Its Turkish validity and reliability was performed by Yenal and Okumuş (2003). LATCH includes five evaluation criteria and consists of the first letters of the English equivalents of these criteria. In the LATCH Scoring System, 0, 1 or 2 points are given for each criterion A minimum score of 0 and a maximum score of 10 can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy.

    Time frame: Pre-test; before the first Su Jok intervention

  5. Breastfeeding Charting System: LATCH

    It was developed by Jensen et al. (1994). Its Turkish validity and reliability was performed by Yenal and Okumuş (2003). LATCH includes five evaluation criteria and consists of the first letters of the English equivalents of these criteria. In the LATCH Scoring System, 0, 1 or 2 points are given for each criterion. A minimum score of 0 and a maximum score of 10 can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy.

    Time frame: On the 3rd day after cesarean section (72 hours postpartum), before the 3rd Su Jok intervention.

  6. Breastfeeding Charting System: LATCH

    It was developed by Jensen et al. (1994). Its Turkish validity and reliability was performed by Yenal and Okumuş (2003). LATCH includes five evaluation criteria and consists of the first letters of the English equivalents of these criteria. In the LATCH Scoring System, 0, 1 or 2 points are given for each criterion. A minimum score of 0 and a maximum score of 10 can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy.

    Time frame: On the 10th day after cesarean section; after the last (10th) Su Jok intervention.

  7. Inadequate Milk Perception Scale

    The scale developed by McCarter-Spaulding and Kearney in 2001 consists of 6 questions to determine inadequate perception of breast milk. The first question questioning whether the mother perceives her milk as sufficient or not is in the form of 'yes' or 'no'. The other 5 questions aim to measure the perception of inadequacy of milk and are scored between 0-10. '0' indicates that milk is perceived as completely inadequate and "10" indicates that milk is perceived as completely adequate. The scale is scored between 0-50. A high score indicates an increased perception of milk sufficiency.

    Time frame: Pre-test; before the first Su Jok intervention

  8. Inadequate Milk Perception Scale

    The scale developed by McCarter-Spaulding and Kearney in 2001 consists of 6 questions to determine inadequate perception of breast milk. The first question questioning whether the mother perceives her milk as sufficient or not is in the form of 'yes' or 'no'. The other 5 questions aim to measure the perception of inadequacy of milk and are scored between 0-10. '0' indicates that milk is perceived as completely inadequate and "10" indicates that milk is perceived as completely adequate. The scale is scored between 0-50. A high score indicates an increased perception of milk sufficiency.

    Time frame: On the 3rd day after cesarean section (72 hours postpartum), before the 3rd Su Jok intervention.

  9. Inadequate Milk Perception Scale; before the 3rd Su Jok intervention

    The scale developed by McCarter-Spaulding and Kearney in 2001 consists of 6 questions to determine inadequate perception of breast milk. The first question questioning whether the mother perceives her milk as sufficient or not is in the form of 'yes' or 'no'. The other 5 questions aim to measure the perception of inadequacy of milk and are scored between 0-10. '0' indicates that milk is perceived as completely inadequate and "10" indicates that milk is perceived as completely adequate. The scale is scored between 0-50. A high score indicates an increased perception of milk sufficiency.

    Time frame: On the 10th day after cesarean section; after the last (10th) Su Jok intervention.

07

Study locations

1 site
  • Şanlıurfa training and research hospital
    Sanliurfa, Eyalet/Yerleşke 63000, Turkey (Türkiye)
08

References and documents

Publications

  • Kilicli A, Sahin A, Yazgu HA, Cakir A. Effect of Su Jok Therapy on perception of insufficient milk, breastfeeding success, and breastfeeding self-efficacy in primiparous women who gave birth by cesarean section: Randomized controlled trial. Explore (NY). 2026 Sep 10;22(6):103531. doi: 10.1016/j.explore.2026.103531. Online ahead of print. PubMed 42743909 ↗

Individual participant data

Plan to share: Yes — All

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: 15 October 2024- 15 October 2025

Access criteria: 15 October 2024- 15 October 2025

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2024 to primary completion in Jan 2025, 3 months.

Of 505 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 3 months is below that.

Counting every sponsor, half of 513 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 3, 2026: primary completion Oct 2025 → Jan 2025 and completion Oct 2025 → Jan 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 3, 2024
First posted
Oct 8, 2024
StartActual
Oct 9, 2024
Primary completionActual
Jan 20, 2025was Oct 2025
CompletionActual
Jan 20, 2025was Oct 2025
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 3, 2026
Sites
1 site added, 1 site removed — first site in Turkey (Türkiye); no longer in Turkey
Show site
  • Şanlıurfa training and research hospital · Sanliurfa, Turkey (Türkiye)
Show 1 removed
  • Şanlıurfa training and research hospital · Şanlıurfa, Turkey
Nov 3, 2026
Primary completion
Oct 15, 2025→Jan 20, 2025 (actual)
Nov 3, 2026
Study completion
Oct 15, 2025→Jan 20, 2025 (actual)
Nov 3, 2026
Primary outcomes
1 edited, 8 time frame changed
What changed in the outcomes
  • EditedInadequate Milk Perception Scale; before the 3rd Su Jok interventionTime frame: 10th day after caesarean section → On the 10th day after cesarean section; after the last (10th) Su Jok intervention.
  • Time frameBreastfeeding Self-Efficacy Scalepre-test → Pre-test; before the first Su Jok intervention
  • Time frameBreastfeeding Self-Efficacy Scale#23rd day after caesarean section → On the 3rd day after cesarean section (72 hours postpartum), before the 3rd Su Jok intervention.
  • Time frameBreastfeeding Self-Efficacy Scale#310th day after caesarean section → On the 10th day after cesarean section; after the last (10th) Su Jok intervention.
  • Time frameBreastfeeding Charting System: LATCHpre-test → Pre-test; before the first Su Jok intervention
  • Time frameBreastfeeding Charting System: LATCH#23rd day after caesarean section → On the 3rd day after cesarean section (72 hours postpartum), before the 3rd Su Jok intervention.
  • Time frameBreastfeeding Charting System: LATCH#310th day after caesarean section → On the 10th day after cesarean section; after the last (10th) Su Jok intervention.
  • Time frameInadequate Milk Perception Scalepre-test → Pre-test; before the first Su Jok intervention
  • Time frameInadequate Milk Perception Scale#23rd day after caesarean section → On the 3rd day after cesarean section (72 hours postpartum), before the 3rd Su Jok intervention.
Nov 3, 2026
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 42743909 ↗
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    Recruiting→Completed
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 42743909 ↗
    1 site added, 1 site removed — first site in Turkey (Türkiye); no longer in Turkey
    Show site
    • Şanlıurfa training and research hospital · Sanliurfa, Turkey (Türkiye)
    Show 1 removed
    • Şanlıurfa training and research hospital · Şanlıurfa, Turkey
    Primary completion Oct 15, 2025→Jan 20, 2025 (now actual)
    Study completion Oct 15, 2025→Jan 20, 2025 (now actual)
    Primary outcomes 1 edited, 8 time frame changed
    What changed in the outcomes
    • EditedInadequate Milk Perception Scale; before the 3rd Su Jok interventionTime frame: 10th day after caesarean section → On the 10th day after cesarean section; after the last (10th) Su Jok intervention.
    • Time frameBreastfeeding Self-Efficacy Scalepre-test → Pre-test; before the first Su Jok intervention
    • Time frameBreastfeeding Self-Efficacy Scale#23rd day after caesarean section → On the 3rd day after cesarean section (72 hours postpartum), before the 3rd Su Jok intervention.
    • Time frameBreastfeeding Self-Efficacy Scale#310th day after caesarean section → On the 10th day after cesarean section; after the last (10th) Su Jok intervention.
    • Time frameBreastfeeding Charting System: LATCHpre-test → Pre-test; before the first Su Jok intervention
    • Time frameBreastfeeding Charting System: LATCH#23rd day after caesarean section → On the 3rd day after cesarean section (72 hours postpartum), before the 3rd Su Jok intervention.
    • Time frameBreastfeeding Charting System: LATCH#310th day after caesarean section → On the 10th day after cesarean section; after the last (10th) Su Jok intervention.
    • Time frameInadequate Milk Perception Scalepre-test → Pre-test; before the first Su Jok intervention
    • Time frameInadequate Milk Perception Scale#23rd day after caesarean section → On the 3rd day after cesarean section (72 hours postpartum), before the 3rd Su Jok intervention.
    + 6 other changes: identifiers, verification date, design details, arm descriptions, contact details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06628960
Lead sponsor
Aysegul Kilicli
Responsible party
Aysegul Kilicli (Gaziantep University, University of Gaziantep) — Sponsor-investigator
First posted
Oct 8, 2024
Start date
Oct 9, 2024
Primary completion
Jan 20, 2025
Completion
Jan 20, 2025
Last update
Nov 3, 2026

Study contacts

AYŞEGÜL KILIÇLI, Assisstan. Prof. PhD.
principal investigator · Muş Alparslan University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion